APPLICATION
ANDA065408
TYPE
ANDA
ORIGINAL APPROVAL
2007-10-15
LATEST ACTION
2007-10-15
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued
Products
EPIRUBICIN HYDROCHLORIDEDiscontinued
EPIRUBICIN HYDROCHLORIDE 200MG/100ML (2MG/ML) · INJECTABLE · INJECTION
EPIRUBICIN HYDROCHLORIDEDiscontinued
EPIRUBICIN HYDROCHLORIDE 50MG/25ML (2MG/ML) · INJECTABLE · INJECTION
EPIRUBICIN HYDROCHLORIDEDiscontinued
EPIRUBICIN HYDROCHLORIDE 150MG/75ML (2MG/ML) · INJECTABLE · INJECTION
EPIRUBICIN HYDROCHLORIDEDiscontinued
EPIRUBICIN HYDROCHLORIDE 10MG/5ML (2MG/ML) · INJECTABLE · INJECTION
Approval history
2007-10-15OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.